Table 1.
Demographic characteristics of the 115 COVID-19 patients.
| Variables | n (%) |
|---|---|
| Age cut-off mean (y) <60 ≥60 |
48 (41.7) 67 (58.3) |
| Sex male female |
61 (53.0) 54 (47.0) |
| Fever (symptom) yes no |
93 (80.9) 22 (19.1) |
| Comorbidities hypertension (Group Ⅰ) diabetes (Group Ⅱ) hypertension + diabetes (Group Ⅲ) others (Group Ⅳ) none |
23 (20.0) 22 (19.1) 11 (9.6) 19 (16.5) 40 (34.8) |
| Severity of the disease common severe critical |
6 (5.2) 101 (87.8) 8 (7.0) |
| Antiviral therapy arbidol lopinavir/ritonavir others none |
63 (54.8) 43 (37.4) 5 (4.3) 4 (3.5) |
| Antibiotic therapy one two or more none |
59 (51.3) 16 (13.9) 40 (34.8) |
| Use Chinese patent medicine or herbal medicine yes no |
105 (91.3) 10 (8.7) |
| Corticosteroid therapy yes no |
14 (12.2) 101 (87.8) |
| Grades of lung lesions on chest CT Ⅰ Ⅱ Ⅲ Ⅳ |
34 (29.6) 29 (25.2) 32 (27.8) 20 (17.4) |